CML is a rare clonal disorder of HSCs associated with t(9;22) resulting in BCR-ABL1 rearrangement and has an annual incidence of 1 to 2 cases per 100,000 individuals [22]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.